Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway

Figure 1

(a) Human pulmonary artery smooth muscle cells (HPASMCs) were cultured for 12 h and 24 h, and the photographs were taken using a light microscope. (b) Immunofluorescence labeling SMMHC (green) and Desmin (red) of HPASMCs. (c) MTT assay was performed to measure cell proliferation of HPASMCs treated with 0-0.18 crude drug g/ml Tanreqing injection (TRQ). (d) MTT assay was performed to measure cell proliferation of HPASMCs treated with CX3CL1 (0-600 ng/ml). (e) MTT assay was performed to measure cell proliferation of HPASMCs treated with cysteine (0-100 nM). (f) MTT assay was performed to measure cell proliferation of HPASMCs treated with SKF96365 (0-500 μM).

(a)

(b)

(c)

(d)

(e)

(f)